We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Results: 5

1.
<b>Figure 2</b>

Figure 2. From: EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the standing committee for international clinical studies including therapeutics (ESCISIT).

 Types of evidence for the diagnosis of gout. CT, controlled trial; RCT, randomised controlled trial.

W Zhang, et al. Ann Rheum Dis. 2006 October;65(10):1301-1311.
2.
<b>Figure 1</b>

Figure 1. From: EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the standing committee for international clinical studies including therapeutics (ESCISIT).

 Elements involved in the diagnosis of gout. CT, computed tomography; MRI, magnetic resonance imaging.

W Zhang, et al. Ann Rheum Dis. 2006 October;65(10):1301-1311.
3.
<b>Figure 3</b>

Figure 3. From: EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the standing committee for international clinical studies including therapeutics (ESCISIT).

 Likelihood ratio (LR) and 95% confidence interval (CI) for various features in the diagnosis of gout. MSU, monosodium urate

W Zhang, et al. Ann Rheum Dis. 2006 October;65(10):1301-1311.
4.
<b>Figure 5</b>

Figure 5. From: EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the standing committee for international clinical studies including therapeutics (ESCISIT).

 Diagnostic ladder of gout: composite 1, rapid pain and swelling; composite 2, composite 1 plus erythema; composite 3, composite 2 plus podagra; composite 4, composite 3 plus hyperuricaemia; composite 5, composite 4 plus tophi; composite 6, composite 5 plus x ray changes; composite 7, composite 6 plus MSU crystals. MSU, monosodium urate; SUA, serum uric acid.

W Zhang, et al. Ann Rheum Dis. 2006 October;65(10):1301-1311.
5.
<b>Figure 4</b>

Figure 4. From: EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the standing committee for international clinical studies including therapeutics (ESCISIT).

 Fagan's nomogram for calculating post‐test probability. (To use this nomogram, first select the point on the pre‐test probability scale on the left that is the local population risk of gout, for example 0.01. Then select the point on the likelihood ratio scale in the middle according to the diagnostic test, for example LR = 10. Where the extension of the line drawn between these two points crosses the post‐test probability scale on the right is the estimated risk of gout, for example 0.1.)

W Zhang, et al. Ann Rheum Dis. 2006 October;65(10):1301-1311.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk